Target (CBDY) Interest & Investment Income (2024 - 2025)
Target (CBDY) reported Interest & Investment Income of $22.0 for Q4 2025, down 99.9% year-over-year from $22025.0 in Q4 2024, and down 91.54% quarter-over-quarter from $260.0 in Q3 2025.
Target (CBDY) Interest & Investment Income (2024 - 2025) Analysis & Trends
Target (CBDY) has 2 years of Interest & Investment Income data on file, last reported at $22.0 in Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $22.0, down 99.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $34062.0 (changed N/A YoY), and the FY2025 annual result was $34062.0, up 10.52% from the prior year.
- Interest & Investment Income slipped to $22.0 in Q4 2025 per CBDY's latest filing, from $260.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $22025.0 in Q4 2024 and troughed at $22.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.00 |
| Sep 30, 2025 | 260.00 |
| Jun 30, 2025 | 17,289.00 |
| Mar 31, 2025 | 16,491.00 |
| Dec 31, 2024 | 22,025.00 |
| Sep 30, 2024 | 8,796.00 |